Botox or the new face of the fight against depression - literature review
<p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Introduction:</span></strong>&l...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2021-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35039 |
_version_ | 1818588835482697728 |
---|---|
author | Martyna Nowińska Magdalena Kozyra Przemysław Raczkiewicz Marlena Kaczerska Natalia Śmiech Joanna Milanowska |
author_facet | Martyna Nowińska Magdalena Kozyra Przemysław Raczkiewicz Marlena Kaczerska Natalia Śmiech Joanna Milanowska |
author_sort | Martyna Nowińska |
collection | DOAJ |
description | <p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Introduction:</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;"> Depression is a common psychiatric disorder leading to high burden especially for some other psychiatric comorbidity. Annually over 43 billion dollars are expended for patients with depression among them 28% are directly for depression and other costs are related to mortality and morbidity due to depression. </span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">The aim of the study: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Paying attention to new options for treating depression – a disease that affects more and more people.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Material and method: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">The research was done by the usage of the PubMed and Google Scholar articles about the topic of: botulinum toxin; depression; treatment.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Description of the state of knowledge: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Injecting Botox into the muscles responsible for expression of anguish or sadness may potentially decrease the patients experience of feelings. Botox reversibly blocks acetylcholine release from neuronal axons into the synapse, inhibiting neuromuscular transmission. If the facial feedback hypothesis is correct, by injecting Botox into the corrugator and procerus muscles, it will reversibly inhibit frown facial expressions and have the capability of propagating or enhancing sad and depressed feelings.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Summary</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">: The results from all randomized control trials proved that botulinum toxin A injection in the glabellar region was associated with significant improvement mood and may be a s</span><span style="font-family: 'Times New Roman'; line-height: 114%;">afe and effective treatment to reduce symptoms of depression.</span></p> |
first_indexed | 2024-12-16T09:31:04Z |
format | Article |
id | doaj.art-5958310078b44e84acc2598e3ed676bb |
institution | Directory Open Access Journal |
issn | 2391-8306 |
language | English |
last_indexed | 2024-12-16T09:31:04Z |
publishDate | 2021-08-01 |
publisher | Kazimierz Wielki University |
record_format | Article |
series | Journal of Education, Health and Sport |
spelling | doaj.art-5958310078b44e84acc2598e3ed676bb2022-12-21T22:36:31ZengKazimierz Wielki UniversityJournal of Education, Health and Sport2391-83062021-08-0111826827510.12775/JEHS.2021.11.08.02827771Botox or the new face of the fight against depression - literature reviewMartyna Nowińska0Magdalena Kozyra1Przemysław Raczkiewicz2Marlena Kaczerska3Natalia Śmiech4Joanna Milanowska5Student Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinStudent Research Group of Applied Psychology, Medical University of LublinDepartment of Applied Psychology, Medical University of Lublin<p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Introduction:</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;"> Depression is a common psychiatric disorder leading to high burden especially for some other psychiatric comorbidity. Annually over 43 billion dollars are expended for patients with depression among them 28% are directly for depression and other costs are related to mortality and morbidity due to depression. </span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">The aim of the study: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Paying attention to new options for treating depression – a disease that affects more and more people.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Material and method: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">The research was done by the usage of the PubMed and Google Scholar articles about the topic of: botulinum toxin; depression; treatment.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Description of the state of knowledge: </span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">Injecting Botox into the muscles responsible for expression of anguish or sadness may potentially decrease the patients experience of feelings. Botox reversibly blocks acetylcholine release from neuronal axons into the synapse, inhibiting neuromuscular transmission. If the facial feedback hypothesis is correct, by injecting Botox into the corrugator and procerus muscles, it will reversibly inhibit frown facial expressions and have the capability of propagating or enhancing sad and depressed feelings.</span></p><p class="MsoNormal" style="text-align: justify; text-justify: inter-ideograph; line-height: 114%;" align="justify"><strong><span style="font-family: 'Times New Roman'; line-height: 114%;">Summary</span></strong><span style="mso-spacerun: 'yes'; font-family: 'Times New Roman'; mso-fareast-font-family: Arial; line-height: 114%; font-size: 12,0000pt;">: The results from all randomized control trials proved that botulinum toxin A injection in the glabellar region was associated with significant improvement mood and may be a s</span><span style="font-family: 'Times New Roman'; line-height: 114%;">afe and effective treatment to reduce symptoms of depression.</span></p>https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35039botulinum toxindepressiontreatment |
spellingShingle | Martyna Nowińska Magdalena Kozyra Przemysław Raczkiewicz Marlena Kaczerska Natalia Śmiech Joanna Milanowska Botox or the new face of the fight against depression - literature review Journal of Education, Health and Sport botulinum toxin depression treatment |
title | Botox or the new face of the fight against depression - literature review |
title_full | Botox or the new face of the fight against depression - literature review |
title_fullStr | Botox or the new face of the fight against depression - literature review |
title_full_unstemmed | Botox or the new face of the fight against depression - literature review |
title_short | Botox or the new face of the fight against depression - literature review |
title_sort | botox or the new face of the fight against depression literature review |
topic | botulinum toxin depression treatment |
url | https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/35039 |
work_keys_str_mv | AT martynanowinska botoxorthenewfaceofthefightagainstdepressionliteraturereview AT magdalenakozyra botoxorthenewfaceofthefightagainstdepressionliteraturereview AT przemysławraczkiewicz botoxorthenewfaceofthefightagainstdepressionliteraturereview AT marlenakaczerska botoxorthenewfaceofthefightagainstdepressionliteraturereview AT nataliasmiech botoxorthenewfaceofthefightagainstdepressionliteraturereview AT joannamilanowska botoxorthenewfaceofthefightagainstdepressionliteraturereview |